Pulmatrix, Inc.PULMNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank8
3Y CAGR-87.2%
5Y CAGR-70.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-87.2%/yr
vs +8.9%/yr prior
5Y CAGR
-70.0%/yr
Recent deceleration
Acceleration
-96.1pp
Decelerating
Percentile
P8
Near historical low
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$38000.00-99.5%
2024$7.17M-53.8%
2023$15.52M-14.9%
2022$18.24M+18.6%
2021$15.38M-1.5%
2020$15.61M+21.5%
2019$12.85M-0.9%
2018$12.97M+26.6%
2017$10.24M-42.1%
2016$17.69M-